Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Altered antigen presentation in mice lacking H2-O

M Liljedahl1, O Winqvist, C D Surh

  • 1The R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121, USA.

Immunity
|March 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Early pathways of maternal mentalization: Associations with child development in the FinnBrain birth cohort study.

Frontiers in psychology·2022
Same author

Publisher Correction: Brain charts for the human lifespan.

Nature·2022
Same author

Brain charts for the human lifespan.

Nature·2022
Same author

The meaning of caring touch for healthcare professionals in an intensive care unit: A qualitative interview study.

Intensive & critical care nursing·2021
Same author

Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.

Scandinavian journal of rheumatology·2020
Same journal

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same journal

Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and adaptive resistance to immunotherapy in solid tumors.

Immunity·2026
Same journal

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
Same journal

Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition.

Immunity·2026
See all related articles

Human Leukocyte Antigen (HLA)-DO acts as a negative regulator of HLA-DM in B cells. This study reveals HLA-DO/H2-O limits HLA-DM activity to specific pH ranges, influencing antigen presentation by B cells.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Human Leukocyte Antigen (HLA)-DM facilitates the release of peptides from MHC class II molecules.
  • The role of HLA-DO as a negative regulator of HLA-DM in B cells is suggested but not fully understood.
  • The physiological function of HLA-DO in antigen presentation remains unclear.

Purpose of the Study:

  • To elucidate the physiological function of HLA-DO in B cell antigen presentation.
  • To investigate the regulatory mechanism of HLA-DM by HLA-DO.

Main Methods:

  • Analysis of antigen presentation in B cells from H2-O knockout mice (lacking the mouse equivalent of HLA-DO).
  • Biochemical assays using purified HLA-DO and HLA-DM molecules.

Related Experiment Videos

Main Results:

  • HLA-DO/H2-O influences the peptide loading of MHC class II molecules.
  • HLA-DO/H2-O limits the pH range in which HLA-DM is enzymatically active.
  • This regulation potentially reduces the presentation of antigens acquired through fluid-phase endocytosis.

Conclusions:

  • HLA-DO/H2-O acts as a modulator of HLA-DM activity by restricting its function to a specific pH.
  • This mechanism may fine-tune B cell-mediated antigen presentation, favoring antigens internalized via membrane immunoglobulin over those from fluid-phase endocytosis.